Category: Insights

“I have seen the influence of specialty society guidelines on payors’ decisions. Other than randomized clinical trials, specialty societies are the first place payors go to get more information.”

“Patients do tend to have more success with appeals when verbalizing the direct effects we are experiencing due to a delay in authorization. I believe having patients be able to do some of the follow-up allows for the opportunity for the patient to not only be proactive, but also not have to be sitting around waiting for an authorization to go through.”